Assenagon Asset Management S.A. / WST
Assenagon Asset Management S.A.’s West Pharmaceutical Svsc Inc Position
Does Assenagon Asset Management S.A. own West Pharmaceutical Svsc Inc (WST)? Yes — 64.8K shares worth $23M (+0.03% of its 13F portfolio) as of Q2 2026, down from 137.6K shares the prior filed quarter.
Position Value
$23M
Q2 2026
Shares
64.8K
% of Portfolio
+0.03%
Quarters Held
28
currently held
Position History WST
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 64.8K | $23M | +0.03% |
| Q1 2026 | 137.6K | $34M | +0.05% |
| Q4 2025 | 251.0K | $69M | +0.10% |
| Q3 2025 | 188.9K | $50M | +0.07% |
| Q2 2025 | 153.5K | $34M | +0.05% |
| Q1 2025 | 234.8K | $53M | +0.09% |
| Q4 2024 | 99.2K | $33M | +0.05% |
| Q3 2024 | 38.7K | $12M | +0.02% |
| Q2 2024 | 25.9K | $9M | +0.02% |
| Q1 2024 | 47.6K | $19M | +0.04% |
| Q4 2023 | 126.3K | $44M | +0.12% |
| Q3 2023 | 15.7K | $6M | +0.02% |
| Q2 2023 | 2.4K | $931,314 | 0.00% |
| Q1 2023 | 19.4K | $7M | +0.02% |
| Q4 2022 | 229.2K | $54M | +0.19% |
| Q3 2022 | 129.2K | $32M | +0.12% |
| Q2 2022 | 22.4K | $7M | +0.03% |
| Q1 2022 | 6.7K | $3M | +0.01% |
| Q4 2021 | 6.2K | $3M | +0.01% |
| Q3 2021 | 27.4K | $12M | +0.04% |
| Q2 2021 | 4.8K | $2M | +0.01% |
| Q1 2021 | 6.4K | $2M | +0.01% |
| Q4 2020 | 17.9K | $5M | +0.02% |
| Q3 2020 | 4.6K | $1M | +0.01% |
| Q2 2020 | 40.2K | $9M | +0.06% |
| Q1 2020 | 11.1K | $2M | +0.01% |
| Q2 2019 | 65.4K | $8M | +0.06% |
| Q1 2019 | 58.5K | $6M | +0.06% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of WST.